Page last updated: 2024-10-24

cannabinol and Sleep Initiation and Maintenance Disorders

cannabinol has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

Cannabinol: A physiologically inactive constituent of Cannabis sativa L.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research Excerpts

ExcerptRelevanceReference
"Insomnia is the most prevalent sleep disorder, with few effective pharmacotherapies."3.30Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. ( D'Rozario, AL; Gordon, CJ; Grunstein, RR; Hoyos, CM; Irwin, C; Lavender, I; Marshall, N; McCartney, D; McGregor, I; Saini, B; Suraev, A; Yee, B, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lavender, I1
McCartney, D1
Marshall, N1
Suraev, A1
Irwin, C1
D'Rozario, AL1
Gordon, CJ1
Saini, B1
Grunstein, RR1
Yee, B1
McGregor, I1
Hoyos, CM1

Trials

1 trial available for cannabinol and Sleep Initiation and Maintenance Disorders

ArticleYear
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
    BMJ open, 2023, 08-23, Volume: 13, Issue:8

    Topics: Cannabinol; Humans; Polysomnography; Randomized Controlled Trials as Topic; Sleep; Sleep Initiation

2023